Wellington Management Group LLP Sells 2,375,023 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Wellington Management Group LLP reduced its position in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 88.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 318,565 shares of the company's stock after selling 2,375,023 shares during the quarter. Wellington Management Group LLP owned approximately 0.11% of Stevanato Group worth $6,942,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of STVN. Captrust Financial Advisors lifted its holdings in Stevanato Group by 12.7% in the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company's stock worth $262,000 after buying an additional 1,480 shares during the period. AMI Asset Management Corp bought a new position in shares of Stevanato Group in the 4th quarter worth about $1,089,000. SG Americas Securities LLC lifted its position in Stevanato Group by 18.2% during the 4th quarter. SG Americas Securities LLC now owns 15,546 shares of the company's stock valued at $339,000 after acquiring an additional 2,389 shares during the period. Jennison Associates LLC bought a new stake in Stevanato Group during the fourth quarter worth about $20,239,000. Finally, Conestoga Capital Advisors LLC increased its stake in shares of Stevanato Group by 5.3% during the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company's stock valued at $176,128,000 after purchasing an additional 407,086 shares in the last quarter.

Analyst Upgrades and Downgrades

STVN has been the topic of several recent research reports. William Blair restated an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. UBS Group dropped their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of €25.70 ($28.88).

Stevanato Group Stock Performance

STVN stock traded down €0.23 ($0.26) on Wednesday, hitting €22.41 ($25.18). The company had a trading volume of 11,805 shares, compared to its average volume of 350,542. The stock has a market cap of $6.79 billion, a price-to-earnings ratio of 47.68, a P/E/G ratio of 7.18 and a beta of 0.52. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The stock's 50-day simple moving average is €20.51 and its 200 day simple moving average is €20.65. Stevanato Group S.p.A. has a 12-month low of €16.56 ($18.61) and a 12-month high of €29.67 ($33.34).

Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, meeting analysts' consensus estimates of €0.20 ($0.22). The company had revenue of €352.68 million during the quarter, compared to analysts' expectations of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. As a group, equities research analysts expect that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.